Common Contracts

Contract

Termination and Asset Transfer Agreement • May 5th, 2020 • New York

• Contract Type
  Termination and Asset Transfer Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

EX-10.2 3 a123114ex102.htm EXHIBIT 10.2 Exhibit 10.2 EXECUTION VERSION STRICTLY CONFIDENTIAL TERMINATION AND ASSET TRANSFER AGREEMENT by and between NOVARTIS PHARMA AG, NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. and ARRAY BIOPHARMA INC. Dated as of November 26, 2014 [***] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Confidential treatment has been requested with respect to this information. TABLE OF CONTENTS

TERMINATION AND ASSET TRANSFER AGREEMENT by and between NOVARTIS PHARMA AG, NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. and ARRAY BIOPHARMA INC. Dated as of November 26, 2014

Termination and Asset Transfer Agreement • February 4th, 2015 • Array Biopharma Inc • Pharmaceutical preparations • New York

• Contract Type
  Termination and Asset Transfer Agreement
• Filed
  February 4th, 2015
• Company
  Array Biopharma Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS TERMINATION AND ASSET TRANSFER AGREEMENT, dated as of November 26, 2014 (together with all Schedules and Exhibits attached hereto, this “Agreement”), is made by and among Novartis Pharma AG, a Swiss corporation (“Novartis”), Novartis International Pharmaceutical Ltd., a corporation organized and existing under the laws of Bermuda, for purposes of Articles II, Section 4.1, Section 5.1(d) and Article X only (“NIP”), and Array BioPharma Inc., a Delaware corporation (“Array”).